hematoxylin has been researched along with Biliary Tract Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, K; Ishige, T; Kawasaki, Y; Matsushita, K; Mishima, T; Nakadai, E; Ohtsuka, M; Sakai, N; Shiko, Y; Suda, R | 1 |
1 other study(ies) available for hematoxylin and Biliary Tract Cancer
| Article | Year |
|---|---|
Prediction of mismatch repair deficient biliary tract cancer: Role of morphological features and host immune response detected by routine hematoxylin-eosin staining.
Topics: Biliary Tract Neoplasms; DNA Mismatch Repair; Eosine Yellowish-(YS); Hematoxylin; Humans; Immunity; Microsatellite Instability; Staining and Labeling | 2021 |